Skip to content
Home/Companies/Biotech/Certis Therapeutics
Certis Therapeutics

Certis Therapeutics

Biotech·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Certis Therapeutics?

Certis Therapeutics is a French Biotech company, currently owned by Grand Sud-Ouest Capital since 2020.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Grand Sud-Ouest Capital
Investor
Grand Sud-Ouest Capital
GSO Innovation · 2018 · Growth

Key facts

HQFrance
SectorBiotech
Websitecertis-therapeutics.com

More from GSO Innovation

Other portfolio companies in the same fund.

iQ Spot
Active
France
Ollow
Active
France
Bohr Energie
Bohr Energie
Active
ClimateTechFrance· 2026
Genoskin
Genoskin
Active
BiotechFrance· 2025
Self & Innov
Self & Innov
Active
FintechFrance· 2024
Ixcys
Ixcys
Active
SoftwareFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Certis Therapeutics?

Certis Therapeutics is currently owned by Grand Sud-Ouest Capital, through GSO Innovation, since 2020.

When did Grand Sud-Ouest Capital acquire Certis Therapeutics?

Grand Sud-Ouest Capital acquired Certis Therapeutics in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue